Immune Response of the Host and Vaccine Development Volume II
A special issue of Pathogens (ISSN 2076-0817). This special issue belongs to the section "Vaccines and Therapeutic Developments".
Deadline for manuscript submissions: 30 August 2024 | Viewed by 251
Special Issue Editors
Interests: host-parasite interacrions; immune modulation by helminths; toxocarosis; skin dirofilariosis; anti-parasitic vaccines
Special Issues, Collections and Topics in MDPI journals
Interests: vaccines; immunology; host-parasite interactions; parasitology
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Vaccines are the key element to efficiently control infectious diseases. They offer what other treatments cannot accomplish—protection. Recently, during the COVID-19 pandemic, thanks to the enormous commitment of researchers from around the world, tremendous progress has been achieved in vaccine development, especially in the field of virus-vectored and mRNA vaccines. Nonetheless, beyond the pandemic, various infectious diseases that we have been aware of for a long time remain dangerous. Successful immunoprophylactic strategies directed against multiple viruses, bacteria, and parasites are still desperately needed. Those pathogens elicit different immune mechanisms in their hosts. Immunization efficacy strictly depends on the proper activation of the host immune system, and therefore, these two aspects of vaccine research should be investigated in parallel. We hope that this Special Issue will offer new insights into the field and help to combine the knowledge on the immune response of the host with vaccine development.
We invite our colleagues in science to submit original as well as review articles related to:
- Immune response to pathogen infections;
- Vaccine antigen identification and validation of its vaccine potential;
- Vaccine formulations: whole pathogen, subunit, vectored, DNA, mRNA;
- Vaccine delivery, i.e., edible vaccines;
- Adjuvant use;
- Host response to vaccination.
Dr. Ewa Długosz
Dr. Agnieszka Wesołowska
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pathogens is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- immunization
- vaccine antigen
- immune response
- infectious diseases
- vaccine development
